Sama Lifesciences
- Business Model
- B2C
- Website
- kindlyhealth.com
- Total Funding
- $3.3M
- Last Round
- $3.3M SeedJul 2022
- Rounds
- 1
About
Sama Lifesciences, operating under the Kindly Health brand, develops home testing kits and digital health services focused on hormonal health and infertility treatment. The company aims to make hormonal healthcare more approachable and accessible by enabling patients to monitor fertility biomarkers from home. The Kindly Health platform provides at-home hormone testing paired with guidance to support people navigating infertility treatment pathways. The Shopify storefront is currently inactive, suggesting the company may have pivoted, paused operations, or rebranded further.
Summary
Sama Lifesciences is a Biotech company. It has raised $3.3M in total across 1 round, most recently a $3.3M Seed round in Jul 2022. Investors include Y Combinator and DG Daiwa Ventures.
Funding History
Jul 2022
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sama-lifesciences"><img src="https://indexed.vc/api/badge/company/sama-lifesciences" alt="Sama Lifesciences on Indexed.vc" width="260" height="76" /></a>